Nilotinib Impurity 1
Nilotinib Impurity 1 is an impurity present in Nilotinib which is a tyrosine kinase inhibitor approved for the treatment of chronic myelogenous leukemia, is used to treat chronic myeloid leukemia (CML) in people who have tested positive for the Philadelphia chromosome.
Additional information
| Catalogue No. | VE006045 |
|---|---|
| CAS No. | N/A |
| Molecular Formula | C28H21ClF3N7O |
| Molecular Weight | 563.96 g/mol |
| IUPAC Name | 3-(5-chloro-4-(pyridin-3-yl)pyrimidin-2-ylamino)-4-methyl-N-(3-(4- methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)benzamide |
| References | Gopireddy, Ramana Reddy, and Arthanareeswari Maruthapillai. “A Stability Indicating Method Development and Validation for Separation of Process Related Impurities and Characterization of Unknown Impurities of Tyrosine Kinase Inhibitor Nilotinib by RP-HPLC, NMR Spectroscopy and ESI-MS.” Materials Today: Proceedings, vol. 40, 2021, pp. S127–38, https://doi.org/10.1016/j.matpr.2020.03.837.? Kondra, S. B., et al. “A |
| Status | In-stock |
